FDA approves new formulations of VIREAD®
US Food and Drug Administration (FDA) has approved Viread® (tenofovir disoproxil fumarate) in combination with other antiretroviral agents for the […]
Say something
Bristol-Myers Squibb Signs Expand Access to Reyataz (atazanavir sulfate) in sub-Saharan Africa and India
Bristol Myers Squibb Company today announced a new agreement to expand access to Reyataz (atazanavir sulfate).
-
-
Flipkart Health+ App Launched
06-04-2022
